Sleep Medicine Reviews
Volume 7, Issue 1 , Pages 81-99 , February 2003

Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS)

  • Heather M. Engleman

      Affiliations

    • Edinburgh Sleep Centre, University of Edinburgh, Edinburgh, UK, University of Glasgow, Glasgow, UK
  • ,
  • Matt R. Wild

      Affiliations

    • University of Edinburgh, Edinburgh, UK, Department of Psychological Medicine, University of Glasgow, Glasgow, UK

References 

  1. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnoea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:1108–1114
  2. Krieger J. Long-term compliance with CPAP therapy in obstructive sleep apnoea patients and in snorers. Sleep. 1996;19:S136–S143
  3. Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnoea patients and nonapneic snorers. Sleep. 1992;15:S42–S46
  4. Lacassagne L, Didier A, Doussau S, Murris-Espin M, Birot P, Charlet JP, et al. Results of 248 patients with sleep apnoea syndrome treated by continuous positive airway pressure ventilation between 1990 and 1995: a study of compliance and outcome of the apnoea-hypopnea index. Revue des Maladies Respiratoires. 2000;17:467–474
  5. Pieters T, Collard P, Aubert G, Dury M, Delguste P, Rodenstein DO. Acceptance and long-term compliance wih nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J. 1996;9:939–944
  6. Waldhorn RE, Herrick TW, Nguyen MC, O»Donnell AE, Sodero J, Potolicchio SJ. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnoea. Chest. 1990;97:33–38
  7. Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnoea. Chest. 1991;100:1019–1023
  8. Meurice J-C, Dore P, Paquereau J, Neau J-P, Ingrand P, Chavagnat J-J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnoea syndrome. Chest. 1994;105:429–433
  9. Fleury B, Rakatonanahary D, Tehindrazanarivelo AD, Hausser-Hauw C, Lebeau B. Long-term compliance to continuous positive airway pressure therapy (nCPAP) set up during a split-night polysomnography. Sleep. 1994;17:512–515
  10. Edinger JD, Carwile S, Miller P, Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnoea. Perceptual and Motor Skills. 1994;78:1116–1118
  11. Kingshott RN, Vennelle M, Hoy CJ, Engleman HM, Deary IJ, Douglas NJ. Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med. 2000;161:866–871
  12. Pépin JL, Krieger J, Rodenstein D, Cornette A, Sforza E, Delguste P, et al. Effective compliance during the first 3 months of continuous positive airway pressure; a European prospective study of 121 patients. Am J Respir Crit Care Med. 1999;160:1124–1129
  13. Reeves-Hoché MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med. 1994;149:149–154
  14. Noseda A, Jann E, Hoffman G, Linkowski P, Kerkhofs M. Compliance with nasal continuous positive airway pressure assessed with a pressure monitor: pattern of use and influence of sleep habits. Respir Med. 2000;94:76–81
  15. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnoea. Am Rev Respir Dis. 1993;147:887–895
  16. Engleman HM, Martin SE, Douglas NJ. Compliance with continuous positive airway pressure therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax. 1994;49:263–266
  17. Weaver TE, Kribbs NB, Pack AI, Kline LR, Chugh DK, Maislin G, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep. 1997;20:278–283
  18. Bennett LS, Langford BA, Stradling JR, Davies RJ. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnoea. Am J Respir Crit Care Med. 1998;158:778–786
  19. Meslier N, LeBrun T, Grillier-Lanoir , Rolland N, Henderick C, Sailly J-C, et al. A French survey of 3225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J. 1998;12:185–192
  20. Janson C, Noges E, Svedberg-Randt S, Lindberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment?. Respir Med. 2000;94:145–149
  21. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy. Chest. 1996;109:1470–1476
  22. Rolfe I, Olson LG, Saunders NA. Long-term acceptance of continuous positive airway pressure in obstructive sleep apnoea. Am Rev Respir Dis. 1991;144:1130–1133
  23. Nino-Murcia G, McCann CC, Bliwise DL, Guilleminault C, Dement WC. Compliance and side effects in sleep apnoea patients treated with nasal continuous positive airway pressure. West J Med. 1989;150:165–169
  24. Hoffstein V, Viner S, Mateika , Conway J. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure; patient compliance, perception of benefits, and side effects. Am Rev Respir Dis. 1992;145:841–845
  25. Pépin JL, Leger P, Veale D, Langevin B, Robert D, Lévy P. Side effects of nasal continuous positive airway pressure in sleep apnoea syndrome. Chest. 1995;107:375–381
  26. Kalan A, Kenyon GS, Seemungal TA, Wedzicha JA. Adverse effects of nasal continuous positive airway pressure therapy in sleep apnoea syndrome. J Laryngol Otol. 1999;113:888–892
  27. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnoea patients. Chest. 1999;116:403–408
  28. Wiest GH, Lehnert G, Bruck WM, Meyer M, Hahn EG, Ficker JH. A heated humidifier reduces upper airway dryness during continuous positive airway pressure therapy. Respir Med. 1999;93:21–26
  29. Reeves-Hoché MK, Meck R, Zwillich CW. Continuous versus bilevel positive airway pressure for obstructive sleep apnoea. Am J Respir Crit Care Med. 1995;151:443–449
  30. Konermann M, Sanner BM, Vyleta M, Laschewski F, Groetz J, Sturm A, et al. Use of conventional and self-adjusting nasal continuous positive airway pressure for treatment of severe obstructive sleep apnoea syndrome: acomparative study. Chest. 1998;113:714–718
  31. Meurice J-C, Marc I, Sériès F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnoea/hypopnea syndrome. Am J Respir Crit Care Med. 1996;153:794–798
  32. Fletcher EC, Luckett RA. The effect of positive reinforcement on hourly compliance in nasal continuous positive airway pressure users with obstructive sleep apnoea. Am Rev Respir Dis. 1991;143:936–941
  33. Hui DS, Chan JK, Choy DK, Ko FW, Li TS, Leung RC, et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest. 2000;117:1410–1416
  34. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnoea/hypopnea syndrome?. Am J Respir Crit Care Med. 1999;159:1096–1100
  35. Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple interventions. Sleep. 1997;20:284–289
  36. Likar LL, Panciera TM, Erickson AD, Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest. 1997;111:1273–1277
  37. Wallston KA. Hocus-pocus the focus isn»t strictly on the locus: Rotter's social learning theory modified for health. Cognitive Theory and Research. 1992;16:183–199
  38. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of CPAP for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:461–467
  39. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnea syndrome. Thorax. 1997;52:114–119
  40. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenburg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med. 1998;157:858–865
  41. Cohen, J, Statistical power analysis for the behavioral sciences. 2nd ed, Erlbaum, New Jersey, 1988
  42. Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med. 1996;154:182–186
  43. Boudewyns A, Grillier-Lanoir V, Willemson MJ, De Cock WA, Van de Heyning PH, De Backer WA. Two months follow-up of auto-CPAP treatment in patients with obstructive sleep apnoea. Thorax. 1999;54:147–149
  44. Ballester E, Badia JR, Hernández L, Carrasco E, De Pablo J, Fornas C, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:495–501
  45. Bosely CM, Fosbury JA, Cochrane GM. Psychological factors associated with poor compliance with treatment in asthma. Eur Respir J. 1995;8:899–904
  46. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelburg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care. 1997;35:1164–1170
  47. Rogers AE, Aldrich MS, Berrios AM, Rosenburg RS. Compliance with stimulant medications in narcolepsy. Sleep. 1997;20:28–33
  48. Kavanagh DJ, Gooley S, Wilson PH. Prediction of adherence in diabetes. Journal of Behavioural Medicine. 1993;16:509–522
  49. Conner, M, Norman, P
  50. Blackburn, I-M, Davidson, K, Cognitive therapy for depression and anxiety. Blackwell, Cambridge 1990.
  51. Hawton, K, Salkovskis, PM, Kirk, J, Clark, DM, Cognitive behaviour therapy for psychiatric problems. Oxford University Press, New York 1989
  52. White, CA, Cognitive behaviour therapy for chronic medical problems: a guide to assessment and treatment in practice. Wiley, Chichester 2001
  53. McFadyen T, Engleman HM, Espie C, Douglas NJ. Psychosocial function before and after CPAP treatment. Eur Respir J. 2001;
  54. Wild M, Espie C, Douglas NJ, Engleman HM. Psychological and clinical predictors of adherence to continuous positive airway pressure therapy for obstructive sleep apnoea: a prospective study. social determinants of adherence to CPAP therapy. Psychologist. 2001;
  55. Engleman HM, McDonald J, Graham D, Lello G, Douglas NJ. Randomized controlled crossover trial of CPAP vs. MRS therapy for the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 2001;163 (5 Suppl):A837
  56. Weaver T, Maislin G, Schwab R, Cantor C, Younger J, Dinges D, et al. Perception of OSA risks and benefit and volition to use CPAP. Am J Respir Crit Care Med. 2001;163 (5 Suppl):A838
  57. Lau RR, Hartman KA, Ware JE. Health as value: methodological and theoretical considerations. Health Psychology. 1986;5:25–42
  58. Jokic R, Klimaszewski A, Sridhar G, Fitzpatrick MF. Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea. Chest. 1998;114:1061–1069

 Correspondence should be addressed to: H. M. Engleman, Edinburgh Sleep Centre, Wd. 48, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh EH3 9YW, UK. Tel: +44 (0) 131-536-2355; fax: +44 (0) 131-536-2362; E-mail: h.engleman@ed.ac.uk

PII: S1087-0792(01)90197-2

doi: 10.1053/smrv.2001.0197

Sleep Medicine Reviews
Volume 7, Issue 1 , Pages 81-99 , February 2003